Chemoinformaics analysis of (2Z,6E)-FARNESYL ACETATE
| Molecular Weight | 264.409 | nRot | 8 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 4 |
| Exact Molecular Weight | 264.209 | nRing | 0 |
| Solubility: LogS | -4.798 | nHRing | 0 |
| Solubility: LogP | 6.603 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 48.6642 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.457 |
| Synth | 2.742 |
| Natural Product Likeliness | 1.932 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.955 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.526 |
| MDCK | 0.0000183 |
| BBB | 0.208 |
| PPB | 0.897525 |
| VDSS | 4.762 |
| FU | 0.059837 |
| CYP1A2-inh | 0.97 |
| CYP1A2-sub | 0.102 |
| CYP2c19-inh | 0.492 |
| CYP2c19-sub | 0.237 |
| CYP2c9-inh | 0.546 |
| CYP2c9-sub | 0.707 |
| CYP2d6-inh | 0.111 |
| CYP2d6-sub | 0.075 |
| CYP3a4-inh | 0.31 |
| CYP3a4-sub | 0.219 |
| CL | 10.421 |
| T12 | 0.179 |
| hERG | 0.014 |
| Ames | 0.004 |
| ROA | 0.005 |
| SkinSen | 0.952 |
| Carcinogencity | 0.343 |
| EI | 0.952 |
| Respiratory | 0.02 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.725614 |